ZK-93426

Last updated
ZK-93426
ZK-93426.svg
Names
Preferred IUPAC name
Ethyl 4-methyl-5-[(propan-2-yl)oxy]-9H-pyrido[3,4-b]indole-3-carboxylate
Other names
ZK-93426
Ethyl 5-isopropoxy-4-methyl-9H-β-carboline-3-carboxylate
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
PubChem CID
  • InChI=1S/C18H20N2O3/c1-5-22-18(21)17-11(4)15-13(9-19-17)20-12-7-6-8-14(16(12)15)23-10(2)3/h6-10,20H,5H2,1-4H3 X mark.svgN
    Key: VMDUABMKBUKKPG-UHFFFAOYSA-N X mark.svgN
  • InChI=1/C18H20N2O3/c1-5-22-18(21)17-11(4)15-13(9-19-17)20-12-7-6-8-14(16(12)15)23-10(2)3/h6-10,20H,5H2,1-4H3
    Key: VMDUABMKBUKKPG-UHFFFAOYAG
  • CCOC(=O)C1=NC=C2C(=C1C)C3=C(N2)C=CC=C3OC(C)C
Properties
C18H20N2O3
Molar mass 312.369 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
X mark.svgN  verify  (what is  Yes check.svgYX mark.svgN ?)

ZK-93426 (ethyl-5-isopropoxy-4-methyl-beta-carboline-3-carboxylate) is a drug from the beta-carboline family. It acts as a weak partial inverse agonist of benzodiazepine receptors, [1] meaning that it causes the opposite effects to the benzodiazepine class of drugs and has anxiogenic properties, [2] although unlike most benzodiazepine antagonists it is not a convulsant and actually has weak anticonvulsant effects. [3] In human tests it produced alertness, restlessness and feelings of apprehension,[ clarification needed ] and reversed the effect of the benzodiazepine lormetazepam. [4] [5] It was also shown to produce nootropic effects [6] [7] and increased release of acetylcholine. [8] [9]

See also

References

  1. ↑ Camerman, A; Mastropaolo, D; Hempel, A; Camerman, N (2005). "Ethyl 5-isopropoxy-4-methyl-beta-carboline-3-carboxylate: structural determinants of benzodiazepine-receptor antagonism". Acta Crystallographica C. 61 (Pt 4): o265–6. Bibcode:2005AcCrC..61O.265C. doi:10.1107/S0108270105005457. PMID   15805647.
  2. ↑ File, SE; Pellow, S; Jensen, LH (1986). "Actions of the beta-carboline ZK 93426 in an animal test of anxiety and the holeboard: interactions with Ro 15-1788". Journal of Neural Transmission. 65 (2): 103–14. doi:10.1007/BF01256486. PMID   3009709. S2CID   7230560.
  3. ↑ Jensen, LH; Petersen, EN; Braestrup, C; Honoré, T; Kehr, W; Stephens, DN; Schneider, H; Seidelmann, D; Schmiechen, R (1984). "Evaluation of the beta-carboline ZK 93 426 as a benzodiazepine receptor antagonist". Psychopharmacology. 83 (3): 249–56. doi:10.1007/BF00464789. PMID   6089247. S2CID   37990146.
  4. ↑ Dorow, R; Duka, T; Höller, L; Sauerbrey, N (1987). "Clinical perspectives of beta-carbolines from first studies in humans". Brain Research Bulletin. 19 (3): 319–26. doi:10.1016/0361-9230(87)90100-6. PMID   2890423. S2CID   54287050.
  5. ↑ Duka, T; Goerke, D; Dorow, R; Höller, L; Fichte, K (1988). "Human studies on the benzodiazepine receptor antagonist beta-carboline ZK 93 426: antagonism of lormetazepam's psychotropic effects". Psychopharmacology. 95 (4): 463–71. doi:10.1007/bf00172956. PMID   2905500. S2CID   25383323.
  6. ↑ Duka, T; Edelmann, V; Schütt, B; Dorow, R (1988). "β-Carbolines as Tools in Memory Research: Human Data with the β-Carboline ZK 93426". Benzodiazepine Receptor Ligands, Memory and Information Processing. Psychopharmacology Series. Vol. 6. pp. 246–60. doi:10.1007/978-3-642-73288-1_18. ISBN   978-3-642-73290-4. PMID   3064085.
  7. ↑ Duka, T; Ott, H; Rohloff, A; Voet, B (1996). "The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills". Psychopharmacology. 123 (4): 361–73. doi:10.1007/BF02246647. PMID   8867876. S2CID   36950692.
  8. ↑ Moore, H; Sarter, M; Bruno, JP (1992). "Age-dependent modulation of in vivo cortical acetylcholine release by benzodiazepine receptor ligands". Brain Research. 596 (1–2): 17–29. doi:10.1016/0006-8993(92)91527-L. PMID   1334777. S2CID   39356368.
  9. ↑ Moore, H; Sarter, M; Bruno, JP (1993). "Bidirectional modulation of stimulated cortical acetylcholine release by benzodiazepine receptor ligands". Brain Research. 627 (2): 267–74. doi:10.1016/0006-8993(93)90330-P. PMID   8298971. S2CID   29549067.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.